Goro Yoshimura
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
-
- Cancer-related Molecular Pathways
Papers in
- Oncology 20
- Cancer Diagnosis and Treatment 9
- Bone health and treatments 5
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 4
- Co-authors
- Qifeng Yang (30 shared papers)Takaomi Suzuma (34 shared papers)Takeo Sakurai (32 shared papers)Teiji Umemura (33 shared papers)Ichiro Mori (24 shared papers)Misa Nakamura (21 shared papers)Yasushi Nakamura (18 shared papers)Takeshi Tamaki (19 shared papers)
- Journals
- Breast Cancer (8 papers)Breast Cancer Research and Treatment (3 papers)Cancer Research (2 papers)Anti-Cancer Drugs (2 papers)Oncology Reports (2 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Goro Yoshimura
52 papers receiving 834 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 202
- Oncology 198
- Genetics 181
- Pathology and Forensic Medicine 106
- Molecular Biology 348
Countries citing papers authored by Goro Yoshimura
This map shows the geographic impact of Goro Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Yoshimura more than expected).
Fields of papers citing papers by Goro Yoshimura
This network shows the impact of papers produced by Goro Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Yoshimura. The network helps show where Goro Yoshimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Goro Yoshimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 83 | |
| 2 | 2001 | 79 | |
| 3 | 2013 | 72 | |
| 4 | 2001 | 54 | |
| 5 | Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. | 2002 | 53 |
| 6 | 2003 | 38 | |
| 7 | 2000 | 36 | |
| 8 | 1999 | 36 | |
| 9 | 2001 | 35 | |
| 10 | 2002 | 35 | |
| 11 | 5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. | 2003 | 33 |
| 12 | 2001 | 29 | |
| 13 | Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. | 2001 | 27 |
| 14 | 2000 | 23 | |
| 15 | 2001 | 23 | |
| 16 | 2004 | 20 | |
| 17 | 2002 | 17 | |
| 18 | 2003 | 16 | |
| 19 | Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer. | 2002 | 16 |
| 20 | Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C. | 2001 | 13 |
About Goro Yoshimura
Goro Yoshimura is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 55 papers that have together received 877 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (9 papers), Breast Cancer Treatment Studies (9 papers), Bone health and treatments (5 papers), Genetics and Neurodevelopmental Disorders (5 papers), Breast Implant and Reconstruction (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (202 citations), Oncology (198 citations), Genetics (181 citations), Pathology and Forensic Medicine (106 citations) and Molecular Biology (348 citations). Goro Yoshimura has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Qifeng Yang, Takaomi Suzuma, Takeo Sakurai, Teiji Umemura, Ichiro Mori, Misa Nakamura, Yasushi Nakamura, Takeshi Tamaki, Kennichi Kakudo and Yozo Kokawa. Their work appears in journals such as Breast Cancer, Breast Cancer Research and Treatment, Cancer Research, Anti-Cancer Drugs and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.